Key facts
- PERCEPTIVE ADVISORS LLC filed SCHEDULE 13G/A for Forte Biosciences, Inc. Common Stock, par value $0.001 per share (FBRX).
- Disclosed ownership: 2.5%.
- Date of event: 31 Dec 2024.
PERCEPTIVE ADVISORS LLC - 31 Dec 2024 SCHEDULE 13G/A Report for Forte Biosciences, Inc. Common Stock, par value $0.001 per share (FBRX)
- Symbol
- FBRX
- Shares outstanding
- 6,557,400 shares
- Disclosed shares
- 163,935 shares
- Ownership percentage
- 2.5%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Feb 2025, 16:15:07 UTC
- Event date
- 31 Dec 2024
- SEC filing
- View on sec.gov
Subject security
Ownership signal
SEC evidence
Key filing fact
PERCEPTIVE ADVISORS LLC disclosed 2.5% ownership in Forte Biosciences, Inc. Common Stock, par value $0.001 per share (FBRX) on 31 Dec 2024.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Feb 2025, 16:15.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (3)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Perceptive Advisors LLC | 2.5% | 163,935 | 0 | 163,935 | /s/ Joseph Edelman | Joseph Edelman, Managing Member | |
| Joseph Edelman | 2.5% | 163,935 | 0 | 163,935 | /s/ Joseph Edelman | Joseph Edelman | |
| Perceptive Life Sciences Master Fund, Ltd. | 2.5% | 163,935 | 0 | 163,935 | /s/ Joseph Edelman | Joseph Edelman, Managing Member |
CIK / CUSIP context first